Immortalization of human corneal endothelial cells using electroporation protocol optimized for human corneal endothelial and human retinal pigment epithelial cells

被引:105
作者
Bednarz, J
Teifel, M
Friedl, P
Engelmann, K
机构
[1] Univ Hamburg, Augenklin Eppendorf, D-20246 Hamburg, Germany
[2] Tech Univ Darmstadt, Inst Biochem, D-64287 Darmstadt, Germany
来源
ACTA OPHTHALMOLOGICA SCANDINAVICA | 2000年 / 78卷 / 02期
关键词
human corneal endothelial cells (HCEC); human retinal pigment epithelial cells (HRPE); transfection; electroporation; immortalization;
D O I
10.1034/j.1600-0420.2000.078002130.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: In this study we established a protocol for transfection of human corneal endothelial and human retinal pigment epithelial cells, This protocol was used for immortalization of human corneal endothelial cells, Methods: Transfection was performed by means of electroporation, For immortalization a plasmid encoding large and small SV40 T-antigen was used. Results: The established electroporation protocol was suitable for both cell types, This protocol was used for transfection of human corneal endothelial cells with a plasmid containing the early region of SV40, The transfected cultures exibited an increased life-span before they entered crisis. One culture recovered from crisis and was cultivated for 300 population doublings. The cells exhibited an in vivo-like morphology usually lost during cell culture. Conclusions: We describe for the first time a culture of SV40 transfected human corneal endothelial cells which recovered from crisis and can therefore be regarded as immortalized.
引用
收藏
页码:130 / 136
页数:7
相关论文
共 39 条
[1]  
ALBERT DM, 1972, ARCH OPHTHALMOL-CHIC, V88, P63
[2]  
BAUM JL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1136
[3]   HLA TYPING FROM HUMAN DONOR EYES [J].
BAUMGARTNER, I ;
HUBERSPITZY, V ;
GRABNER, G ;
MAYR, WR .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1989, 227 (06) :541-543
[4]  
Bednarz J, 1998, IN VITRO CELL DEV-AN, V34, P149
[5]  
BOHNKE M, 1991, CURR OPIN OPHTHALMOL, V2, P432
[6]  
CHANG SE, 1985, BIOCHIM BIOPHYS ACTA, V823, P161
[7]  
DANNENBERG AM, 1981, METHODS STUDYING MON, P375
[8]  
ENGELMANN K, 1989, IN VITRO CELL DEV B, V25, P1065
[9]  
ENGELMANN K, 1988, INVEST OPHTH VIS SCI, V29, P1656
[10]  
ENGELMANN K, 1995, CORNEA, V14, P62